An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Recap by typeshit. Full story at Health on MSN.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
Semafor reports South Africa has Africa's highest adult obesity rate at 30%, yet branded weight loss drugs remain too expensive for most people there.
The Pennsylvania county is funding a study into whether the GLP-1 drug can help people with substance use disorders.
Amy Maxmen reports on how experimental peptides are being hyped in optimization circles and where the talk goes wrong.
Loading…